Literature DB >> 20595063

P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.

Nhi Huynh1, Kevin H Liu, Graham S Baldwin, Hong He.   

Abstract

The p21-activated kinase (PAK) family of serine/threonine kinases plays an important role in cell proliferation, survival and motility, as well as in cell transformation and tumor progression. PAK1 promotes transformation through facilitating the ERK/MAPK pathway and enhances cell migration and survival by stimulating AKT. PAK1 expression increases with the progression of colorectal cancer (CRC). In this study, we have investigated the importance of PAK1 in the biology of colon cancer cells. Reduction of PAK1 expression decreased the activities of ERK and AKT leading to decreased cell proliferation, migration/invasion, and survival. Dual inhibition of ERK and AKT suppressed these cellular processes to levels comparable to those achieved by reduction of PAK1 expression, whereas inactivation of either the ERK or AKT pathway alone partially inhibited cell migration/invasion and survival and had no effect on proliferation. We conclude that PAK1 stimulates colon cancer cell proliferation, migration/invasion, and survival via ERK- and AKT-dependent pathways. These findings establish the central importance of PAK1 in CRC signal transduction and clarify the mechanism by which PAK1 regulates CRC growth and migration. Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595063     DOI: 10.1016/j.bbamcr.2010.05.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  40 in total

1.  Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo.

Authors:  Bohan Yang; Dandan Yu; Jingwen Liu; Kunyu Yang; Gang Wu; Hongli Liu
Journal:  Tumour Biol       Date:  2015-02-04

2.  p21-activated kinase 1 (PAK1) can promote ERK activation in a kinase-independent manner.

Authors:  Zhipeng Wang; Meng Fu; Lifeng Wang; Juanjuan Liu; Yuhua Li; Cord Brakebusch; Qibing Mei
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

Review 3.  p21-Activated Kinases in Thyroid Cancer.

Authors:  Luis Bautista; Christina M Knippler; Matthew D Ringel
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

4.  Glaucarubinone inhibits colorectal cancer growth by suppression of hypoxia-inducible factor 1α and β-catenin via a p-21 activated kinase 1-dependent pathway.

Authors:  Nhi Huynh; John A Beutler; Arthur Shulkes; Graham S Baldwin; Hong He
Journal:  Biochim Biophys Acta       Date:  2014-10-22

5.  Contra-regulation of calcium- and integrin-binding protein 1-induced cell migration on fibronectin by PAK1 and MAP kinase signaling.

Authors:  Meghna U Naik; Ulhas P Naik
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

6.  Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma.

Authors:  Soumya C Iyer; Ashidha Gopal; Devaraj Halagowder
Journal:  Mol Cell Biochem       Date:  2015-06-24       Impact factor: 3.396

7.  Glaucarubinone Combined with Gemcitabine Improves Pancreatic Cancer Survival in an Immunocompetent Orthotopic Murine Model.

Authors:  Dannel Yeo; Nhi Huynh; John A Beutler; Graham S Baldwin; Hong He; Mehrdad Nikfarjam
Journal:  J Invest Surg       Date:  2016-03-30       Impact factor: 2.533

8.  Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer.

Authors:  Nhi Huynh; Arthur Shulkes; Graham Baldwin; Hong He
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

9.  Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases.

Authors:  Dannel Yeo; Nhi Huynh; John A Beutler; Christopher Christophi; Arthur Shulkes; Graham S Baldwin; Mehrdad Nikfarjam; Hong He
Journal:  Cancer Lett       Date:  2014-01-31       Impact factor: 8.679

10.  Blockage of PAK1 alleviates the proliferation and invasion of NSCLC cells via inhibiting ERK and AKT signaling activity.

Authors:  P Song; B Song; J Liu; X Wang; X Nan; J Wang
Journal:  Clin Transl Oncol       Date:  2020-09-24       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.